COMMUNIQUÉS West-GlobeNewswire

NewLink Genetics Announces Final Results from Phase 2 Studies of Indoximod in Advanced Melanoma and Metastatic Pancreatic Cancer to be Presented at ASCO 2018
16/05/2018
AMES, Iowa, May 16, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) today announced that abstracts from two Phase 2 studies of indoximod, used in combination with other agents, are now available on [...]
miRagen Therapeutics to Present New Interim Data From Phase 1 Clinical Trial of Cobomarsen at the 2018 American Society of Clinical Oncology Annual Meeting
16/05/2018
BOULDER, Colo., May 16, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN ), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced today [...]
GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences Announce Publication in The New England Journal of Medicine of a Phase 3 Study of Epidiolex® (cannabidiol oral solution) in Lennox-Gastaut Syndrome
16/05/2018
– First dose-ranging study comparing pharmaceutical formulation of cannabidiol to placebo as add-on therapy in Lennox-Gastaut syndrome, a rare, severe and difficult to treat form of childhood-onset epilepsy – – Both [...]
Oncology Venture Announces Abstracts on Three Pipeline Products Selected for 2018 ASCO Clinical Meeting
16/05/2018
Phase 1 Study of PARP Inhibitor 2X-121 Selected as Oral Presentation June 1, 2018 HOERSHOLM, Denmark and CAMBRIDGE, Mass., May 16, 2018 (GLOBE NEWSWIRE) -- Oncology Venture AB (OV:ST) (“OV” or the “Company”) announced [...]
Molecular Templates to Present Clinical Data at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018
16/05/2018
ASCO Posters to Feature Data on MT-3724 and Evofosfamide AUSTIN, Texas, May 16, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM ) a clinical stage biopharmaceutical company focused on the discovery and [...]
Oncolytics Biotech® Announces Publication of REOLYSIN® Abstract for the ASCO 2018 Annual Meeting
16/05/2018
CALGARY, Alberta and SAN DIEGO, May 16, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (TSX: ONC ) (OTCQX:ONCYF), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus [...]
Ziopharm Oncology to Present Data from Clinical Studies of Controlled IL-12 in Breast Cancer and Glioblastoma at American Society of Clinical Oncology (ASCO) Annual Meeting
16/05/2018
- Data from biopsies shows Ad-RTS-hIL-12 plus veledimex recruits killer T cells into breast and brain cancers - IL-12 continues to demonstrate activity as a single-agent therapy, prolongs survival in patients with [...]
GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences Announce Publication in The New England Journal of Medicine of a Phase 3 Study of Cannabidiol Oral Solution in Lennox-Gastaut Syndrome
16/05/2018
– First dose-ranging study comparing pharmaceutical formulation of cannabidiol to placebo as add-on therapy in Lennox-Gastaut syndrome, a rare, severe and difficult to treat form of childhood-onset epilepsy – – Both [...]
Clearside Biomedical to Present at the 2018 UBS Global Health Care Conference
16/05/2018
ALPHARETTA, Ga., May 16, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, [...]
Ascendis Pharma A/S Announces First Quarter 2018 Financial Results and Business Update Conference Call on May 30
16/05/2018
COPENHAGEN, Denmark, May 16, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND ), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs, today [...]
Biothera Pharmaceuticals Appoints Andrew D.C. LaFrence Chief Financial Officer
16/05/2018
EAGAN, Minn., May 16, 2018 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc., announced the appointment of Andrew D.C. LaFrence, CPA as Senior Vice President and Chief Financial Officer, effective May 29. Biothera [...]
Fibrocell Announces Oral Presentation at 7th International Investigative Dermatology Meeting
16/05/2018
Highlighting Interim Data from Phase 1/2 Clinical Trial of FCX-007 Gene Therapy Candidate for Recessive Dystrophic Epidermolysis Bullosa EXTON, Pa., May 16, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC [...]
Adherium Launches the Hailie™ Global Brand to Connect People with Asthma and COPD to Better Care
16/05/2018
SAN MATEO, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), an award-winning digital health company that improves medication adherence, patient outcomes and engagement, today announced the launch of the [...]
CORRECTING AND REPLACING: Hemispherx Biopharma Reports First Quarter 2018 Financial Results and Provides Business Update
16/05/2018
ORLANDO, Fla., May 16, 2018 (GLOBE NEWSWIRE) -- In a release issued earlier today by Hemispherx Biopharma, Inc. (NYSE American:HEB) with the same headline, the net loss from operations was incorrect in the fourth [...]
Aquinox to Present at 2018 UBS Global Healthcare Conference
16/05/2018
VANCOUVER, British Columbia, May 16, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“ Aquinox ”) (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to [...]
NeuroSearch and Teva Pharmaceutical International enter into agreement on outstanding obligations
16/05/2018
Announcement 16 May 2018 NeuroSearch has today entered into an agreement with, among others, Teva Pharmaceutical International GmbH (Teva), to release Teva from all outstanding obligations pursuant to the agreement from [...]
HEALTH FOUNDATION OF SOUTH FLORIDA AWARDS GRANTS TO FIVE LOCAL ORGANIZATIONS TOTALING $458,824
16/05/2018
The combined impact of the funding is expected to reach and improve health for thousands of residents MIAMI,FL-, May 16, 2018 (GLOBE NEWSWIRE) -- Health Foundation of South Florida’s Board of Directors recently approved [...]
CROSSJECT : Point d'activité mai 2018
16/05/2018
Communiqué de Presse Point d'activité mai 2018 Nouvelle étape dans l'industrialisation Négociations commerciales en bonne voie Confirmation de l'objectif de dépôts de demande d'AMM [1] Dijon, le 16 mai 2018 CROSSJECT ( [...]
Cesca Prices $5.5 Million Public Offering
16/05/2018
RANCHO CORDOVA, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced the [...]

Pages